Swipe om te navigeren naar een ander artikel
The objective of this study was to evaluate the psychometric properties of the Dysmenorrhea Daily Diary (DysDD), an electronic patient-reported outcome, in a sample of 355 women with primary dysmenorrhea enrolled in a phase IIb, multicenter, randomized, partially blinded, placebo-controlled trial for treatment of dysmenorrhea.
Subjects completed the DysDD over three menstrual cycles, one pre-treatment baseline cycle and two treatment cycles. The DysDD was administered alongside the Menstrual Distress Questionnaire (MDQ), the Short-Form 36 Version 2.0 (SF-36v2), and a Global Assessment of Change (GAC). Item response distributions, test–retest reliability, concurrent and known groups validity, responsiveness, and minimally important difference (MID) were evaluated for the DysDD.
As expected, item response distributions varied throughout the menstrual period for all items, with the response scales fully utilized. Within-cycle test–retest reliability was adequate (weighted kappa: 0.5–0.7), although between-cycle test–retest was poor (weighted kappa: 0.1–0.5), most likely due to the highly variable nature of dysmenorrhea between cycles rather than limitations of the measure. Correlations with the MDQ and SF-36v2 were low-moderate, but in the predicted direction, supporting concurrent validity. There were significant differences in DysDD scores across severity groups based on pain medication use. The DysDD was responsive to changes in patients’ dysmenorrhea with significantly different changes in scores between change groups (p < 0.0001). MID analyses suggest changes on the DysDD 0–10 pelvic pain score of three points can be considered clinically meaningful.
Overall, findings indicate that the DysDD has acceptable reliability and is a valid and responsive instrument for assessing dysmenorrhea.
Log in om toegang te krijgen
Met onderstaand(e) abonnement(en) heeft u direct toegang:
Coco, A. S. (1999). Primary dysmenorrhea. American Family Physician, 60(2), 489–496. PubMed
Food and Drug Administration (FDA) (2009). Guidance for industry: Patient-reported outcome measures—use in medical product development to support labeling claims. http://www.fda.gov/downloads/Drugs/Guidances/UCM193282.pdf.
European Medicines Agency (2005). Reflection paper on the regulatory guidance for the use of health-related quality of life (HRQL) measures in the evalutation of medicinal products. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003637.pdf.
Chesney, M. A., & Tasto, D. L. (1975). The development of the menstrual symptom questionnaire. Behavioural Research and Theory, 13(4), 237–244. CrossRef
Nguyen, A. M., Humphrey, L., Kitchen, H., Rehman, T., & Norquist, J. M. (2014). A qualitative study to develop a patient-reported outcome for dysmenorrhea. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. doi: 10.1007/s11136-014-0755-z.
Wild, D., Grove, A., Martin, M., Eremenco, S., McElroy, S., Verjee-Lorenz, A., et al. (2005). Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: Report of the ISPOR task force for translation and cultural adaptation. Value in Health, 8(2), 94–104. CrossRefPubMed
Nunnally, J. C., Bernstein, I. H. (1994). Psychometric theory. New York: McGraw-Hill.
Sloan, J., Symonds, T., Vargas-Chanes, D., & Fridley, B. (2003). Practical guidelines for assessing the clinical significance of health-related quality of life changes within clinical trials. Drug Information Journal, 37(1), 23–31. CrossRef
Habiba, M., Julian, S., Taub, N., Clark, M., Rashid, A., Baker, R., et al. (2010). Limited role of multi-attribute utility scale and SF-36 in predicting management outcome of heavy menstrual bleeding. European Journal of Obstetrics and Gynecology and Reproductive Biology, 148(1), 81–85. CrossRefPubMed
- Psychometric validation of the dysmenorrhea daily diary (DysDD): a patient-reported outcome for dysmenorrhea
Allison M. Nguyen
Josephine M. Norquist
- Springer International Publishing